Condition
Hemophilia A and B
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed2
Not Yet Recruiting2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07421154Not ApplicableNot Yet RecruitingPrimary
Study of a Smart Sharps Disposal Device in Patients With Hemophilia
NCT06747416Phase 2Not Yet RecruitingPrimary
KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors
NCT04055051CompletedPrimary
ATHN 11: Liver Transplantation Outcomes Study
NCT03597022Phase 2TerminatedPrimary
Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors
NCT02776826CompletedPrimary
World Bleeding Disorders Registry Pilot Study
Showing all 5 trials